Back to Search Start Over

Gait Measures as Predictors of Poststroke Cognitive Function

Authors :
Natan M. Bornstein
Jeffrey M. Hausdorff
Shani Shenhar-Tsarfaty
Nir Giladi
Eitan Auriel
Einor Ben Assayag
Amos D. Korczyn
Hen Hallevi
Anat Mike
Efrat Kliper
Aner Weiss
Anat Mirelman
Anat Halevy
Ludmila Shopin
Source :
Stroke. 46:1077-1083
Publication Year :
2015
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2015.

Abstract

Background and Purpose— Patients with stroke are at risk for developing cognitive impairment. We tested whether the assessment of balance and gait can enhance the prediction of long-term cognitive outcome in stroke survivors. Methods— Participants were patients with first-ever, mild-moderate ischemic stroke or transient ischemic attack from the Tel Aviv Brain Acute Stroke Cohort (TABASCO) study, a large prospective cohort study, who underwent 3-T MRI and were followed for ≥2 years using neurological, neuropsychological, and mobility examinations 6, 12, and 24 months after the index event. Results— Data were available for 298 patients (age: 66.7±9.6 years). Forty-six participants (15.4%) developed cognitive decline (CD) over the 2 years of follow-up. The CD group and cognitively intact group did not differ in their neurological deficits or in their infarct volume or location. Nonetheless, 6 months after stroke, the Timed Up and Go test took longer in those who later developed CD ( P P P P =0.006). Separate analyses of the patients with transient ischemic attack revealed similar results. Multivariate regression analysis showed that Timed Up and Go times >12 s at 6 months after stroke/transient ischemic attack was a significant independent risk marker of CD 24 months after stroke (odds ratio=6.07, 95% confidence interval: 1.36–27.15). Conclusions— These results suggest that measures of balance and gait are significant risk markers of cognitive status 2 years after stroke. Relatively simple, performance-based tests of mobility may enhance the identification of stroke/transient ischemic attack survivors who have an increased risk of developing CD. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT01926691.

Details

ISSN :
15244628, 00392499, and 01926691
Volume :
46
Database :
OpenAIRE
Journal :
Stroke
Accession number :
edsair.doi.dedup.....32ea2c5c7e7fd9d8d04c8a9aa335eaca
Full Text :
https://doi.org/10.1161/strokeaha.114.007346